<DOC>
	<DOCNO>NCT02077374</DOCNO>
	<brief_summary>The purpose study determine safety efficacy IDN-6556 compare placebo patient diagnose fat deposit liver ( cause alcohol ) abnormal liver test</brief_summary>
	<brief_title>A Study IDN-6556 Subjects With NAFLD Raised Transaminases</brief_title>
	<detailed_description>This double-blind , randomize study evaluate effect IDN-6556 serum transaminase pharmacodynamics IDN-6556 subject non-alcoholic fatty liver disease elevate alanine aminotransferase .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Male female subject minimum adult legal age ( accord local law sign informed consent document ) , able provide write informed consent , understand comply requirement study Diagnosis nonalcoholic fatty liver disease ( NAFLD ) evidence image diagnostic assessment Alanine aminotransferase ( ALT ) level ≥1.5 x ULN least two occasion , seven day apart , Screening period alphafetoprotein ( AFP ) ≤ 100 ng/mL Hemoglobin ≥10 g/dL , platelet count ≥ 100 x 10^9/L , white blood cell count ≥ 3.0 x 10^9/L If metformin , sulfonylurea , statin , fibrates , subject must stable dose drug least three month prior Screening study Known infection HIV , HCV , HBV Decompensated severe liver disease evidence one following : 1 . Confirmed cirrhosis suspicion cirrhosis 2 . Esophageal varix 3 . Ascites 4 . Suspicion portal hypertension 5 . Hospitalization liver disease within 60 day screen 6 . Bilirubin &gt; 2 x ULN , ALT AST &gt; 10 x ULN Inflammatory bowel disease Diagnosed suspected systemic lupus erythematosus ( SLE ) and/or rheumatoid arthritis ( RA ) Hepatocellular carcinoma ( HCC ) entry study History active nonliver malignancy curatively treat skin cancer ( basal cell squamous cell carcinoma ) Significant systemic major illness liver disease , include coronary artery disease , cerebrovascular disease , pulmonary disease , renal insufficiency , and/or serious psychiatric disease , , opinion Investigator would preclude subject participate complete study History presence alcohol abuse , define consumption 210 mL alcohol per week ( equivalent 14 4ounce glass wine 14 12ounce cans/bottles beer wine cooler ) , substance abuse within prior two year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>NAFLD</keyword>
	<keyword>NASH</keyword>
</DOC>